Jin Medical International Profit Margin

The latest profit margin for ZJYL is 3.66% as of March 2026. That compares with 14.48% in the prior-year period — down 74.7% year over year. That is below the sector sector average of 22.52%. Investors often review this figure alongside Jin Medical International's historical trend and sector peers before judging valuation or financial health.

Over the past year, ZJYL's profit margin moved from 14.48% to 3.66% — a 74.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Jin Medical International's valuation or profitability profile.

Against its sector companies, ZJYL currently prints 3.66% for profit margin, while the sector average sits near 22.52%. That is roughly 83.7% below the sector mean. Large gaps often invite a closer look at Jin Medical International's growth, margins, and balance sheet.

Profit Margin shows how effectively Jin Medical International converts resources into returns. At 3.66%, ZJYL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14.48% in the prior-year period — down 74.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ZJYL's profit margin (3.66%), review year-over-year change from 14.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.